Setup

Quantum Computing Inc. (QUBT, ≈$2.5B market cap, $682K FY2025 organic revenue) filed an 8-K/A on April 17 adding the required audited financials for its February 2026 acquisition of Luminar Semiconductor Inc. The disclosures reveal a specific pattern — 79.8% goodwill allocation on a distressed target whose seller had already fully impaired all its own goodwill to zero — that, on cross-ticker check, repeats at sector flagship IONQ at roughly 20x scale.

What the filings say

From the LSI audit (8-K/A Exhibit 99.2):

• LSI gross margin collapsed from 26.6% to 11.6% in FY2025 on "financial hurdles and decline in shipments due to slower production ramps"
• 28% of FY2025 LSI revenue ($8.4M of $29.8M) came from bankrupt parent Luminar Technologies — non-recurring post-acquisition
• All three LSI subsidiaries (Optogration, Freedom Photonics, EM4) had goodwill fully impaired to zero ($5.6M written off across 2024–2025) before QUBT acquired the group. EM4 was itself a distressed 2024 Luminar acquisition with cancelled government contracts
• QUBT paid $108.5M for a company with $(60.8)M stockholders' deficit, allocating $86.5M (79.8% of purchase price) to goodwill

From the IONQ 10-K (February 25, 2026, Note 3 Business Combinations):

• Six 2025 acquisitions totaling ≈$2.66B consideration, ≈$1.97B goodwill (74%)
• Oxford Ionics: $1.59B paid, $1.26B goodwill (79.4%), revenue "not material" three months post-close
• Lightsynq: $306M paid, $236M goodwill (77%), revenue "not material" post-close
• 39% of IONQ FY2025 reported revenue came from acquired entities — EY flagged as critical audit matter
• SkyWater acquisition pending (≈$1B cash outlay, H1 2026, target is a struggling public semiconductor foundry)

QBTS acquired Quantum Circuits (Yale dual-rail qubit pre-revenue spinout) on January 20 for $250M cash + 10.43M QBTS shares. PPA disclosure is overdue on the 75-day 8-K/A window that closed April 5. RGTI shows no 2025/2026 acquisitions per its 10-K — organic only, no goodwill on balance sheet, same sector narrative multiple.

What the market thinks

IONQ at $46, RSI 85.8, +60% one-week, ≈$16B market cap. Options imply 9% probability of a -50% drawdown over 272 days. Vol P/C 0.20 shows aggressive retail call flow. OTM put skew +29.7% — the market prices tail risk but not moderate downside.

An organic fair-value anchor for IONQ: $79M organic revenue × 30x (generous pre-profit multiple) + $2.5B net cash + $1.5–2B honest mark on acquired intangibles ≈ $18–21 per share. Against $46 market, options price a 50% re-rate at 9% probability. The asymmetry sits in the moderate-downside zone the options do not price — a 25–50% draw toward fair value.

Why the gap exists

Consensus reads quantum names as organically scaling revenue companies. The filings describe cash-rich narrative shells buying pre-revenue or bankruptcy-exit assets, marking 60–80% of purchase price to goodwill on "assembled workforce" and "future synergies," and reporting combined revenue alongside organic. Individually each deal looks like normal R&D-heavy tech M&A. Synthesized across QUBT–LSI, IONQ–Oxford Ionics, IONQ–Lightsynq, and QBTS–Quantum Circuits, the 74–80% goodwill allocations on targets with zero revenue or prior full-impairment histories look like a sector template for converting raised equity into reported "revenue." Cross-ticker synthesis of acquisition accounting across these primary filings is not standard sell-side coverage.

Risks, ranked by impact

1. Narrative reflexivity. Stock at multi-hundred-x revenue funds more acquisitions, which extends the narrative, which supports the stock. IONQ +60% in one week means the template is currently accelerating, not cracking.
2. Borrow cost on solo shorts. IONQ short borrow is likely 15–25% annualized; QUBT probably north of 50%. Carry eats the thesis unless catalysts arrive soon.
3. Technical feasibility cannot be dismissed from filings. If Oxford Ionics delivers production-grade ion-trap systems in 2026–2027, the goodwill mark becomes justified. The accounting pattern is diagnostic, not conclusive.
4. Squeeze risk. Short interest is 22% on IONQ, 28.6% on QUBT, 16.4% on QBTS. Adverse positioning unwinds are violent.
5. QBTS Quantum Circuits PPA discloses under 50% goodwill would weaken the sector-template argument.

Catalysts

• Before April 30, 2026: QUBT proxy statement (share-authorization vote, dilution enabler)
• Late April / early May: QUBT Q1 earnings — first LSI-integrated quarter
• Early May: IONQ Q1 earnings — acquired-revenue disclosure in MD&A
• Mid-May: QBTS Q1 earnings or overdue 8-K/A on Quantum Circuits PPA
• H1 2026 (Q2): SkyWater close with final PPA
• Q4 2026: Annual goodwill impairment testing window opens

What would change our mind

• QBTS Quantum Circuits PPA discloses below 50% goodwill → the pattern is not systematic
• IONQ Q1 10-Q shows acquired-revenue contribution below 25% (declining from FY2025's 39%) → integration is producing organic revenue
• Oxford Ionics revenue ramps materially by the Q2 2026 10-Q → goodwill mark becoming supportable
• Any quantum name takes an impairment on an acquired reporting unit with no stock-price response → market genuinely ignores the accounting → thesis untradable even if directionally correct
• QUBT secondary offering post-proxy at prices above current levels → narrative holding despite dilution pressure

Evidence